Shinpoong Pharmaceutical Co Revenue 2024

Shinpoong Pharmaceutical Co Revenue

200.23 B KRW

Shinpoong Pharmaceutical Co Dividend yield

0.76 %

Ticker

019170.KS

ISIN

KR7019170000

In 2024, Shinpoong Pharmaceutical Co's sales reached 200.23 B KRW, a -4.33% difference from the 209.29 B KRW sales recorded in the previous year.

The Shinpoong Pharmaceutical Co Revenue history

YEARREVENUE (undefined KRW)GROSS MARGIN (%)
2023200.2340,09
2022209.2937,26
2021189.2440,89
2020197.7538,70
2019189.7240,16
2018187.3940,50
201718543,31
2016194.1545,29
2015195.9544,24
2014220.2945,83
2013215.9644,23
2012221.1740,42
2011229.6944,90
2010230.9147,37
2009217.2648,58
2008188.1450,94
2007165.9248,15
2006158.7748,86
2005152.6547,79
2004140.8343,75

Shinpoong Pharmaceutical Co Aktienanalyse

What does Shinpoong Pharmaceutical Co do?

Shinpoong Pharmaceutical Co Ltd is a leading pharmaceutical company in South Korea with a history dating back to 1962. It was founded by Cho Yong-Hwan and is headquartered in Seoul, the capital of South Korea. Shinpoong has gained a strong position in the global market for pharmaceutical products over the years and is known for the development, production, and marketing of medications for various diseases. In its early years, Shinpoong primarily focused on generic drugs, but the company has expanded its activities and now also deals with other industries and markets. The company now produces a wide variety of prescription medications, including those for cardiovascular diseases, cancer, infectious diseases, and mental disorders. Shinpoong has also specialized in medical plants and offers a wide range of plant-based products. In recent years, Shinpoong has evolved its business strategy to adapt to changing market conditions. An important strategy of Shinpoong is the expansion into foreign markets. The company has placed a strong focus on creating partnerships with other companies to strengthen its presence overseas and expand its reach worldwide. Overall, the company encompasses four distinct business divisions: Pharmaceutical Products, Medical Plants, OEM, and the sale of cosmetic products. Each of these divisions specializes in a specific market and offers a variety of products. The pharmaceutical division of Shinpoong is the most important and well-known part of the company, offering a wide range of prescription medications. Shinpoong specializes in the treatment of critical diseases and produces some of the most important medications for cardiovascular diseases, cancer, diabetes, and more. The medical plants division of Shinpoong is another important business division that focuses on the production of herbal medications for a variety of diseases. Shinpoong produces a wide range of herbal products for the treatment of inflammation, pain, and immune problems. The OEM division of Shinpoong specializes in contract manufacturing for other companies. Shinpoong manufactures a variety of products for other companies, including pharmaceutical and food products, as well as medical devices. Finally, Shinpoong offers cosmetic products for oral health. The company manufactures a wide range of products for dental health, including toothpaste and mouthwash. The company is committed to improving the quality and safety of its products to meet customer demands and regulatory requirements. It is committed to providing a high level of service quality and customer satisfaction. In summary, Shinpoong Pharmaceutical Co Ltd is a leading company in the Korean and global pharmaceutical industry. The company has expanded its activities in the areas of medicine, medical plants, OEM, and cosmetic products to meet the needs of consumers. Shinpoong remains committed to delivering high-quality products and services and expanding its presence in the industry. Shinpoong Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Shinpoong Pharmaceutical Co's Sales Figures

The sales figures of Shinpoong Pharmaceutical Co originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Shinpoong Pharmaceutical Co’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Shinpoong Pharmaceutical Co's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Shinpoong Pharmaceutical Co’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Shinpoong Pharmaceutical Co Stock

How much revenue did Shinpoong Pharmaceutical Co generate this year?

Shinpoong Pharmaceutical Co has achieved a revenue of 200.23 B KRW this year.

How much was the turnover of the company Shinpoong Pharmaceutical Co compared to the previous year?

The revenue of Shinpoong Pharmaceutical Co has increased by -4.33% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Shinpoong Pharmaceutical Co?

The revenue of Shinpoong Pharmaceutical Co is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Shinpoong Pharmaceutical Co measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Shinpoong Pharmaceutical Co so important for investors?

The revenue of Shinpoong Pharmaceutical Co is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Shinpoong Pharmaceutical Co pay?

Over the past 12 months, Shinpoong Pharmaceutical Co paid a dividend of 100 KRW . This corresponds to a dividend yield of about 0.76 %. For the coming 12 months, Shinpoong Pharmaceutical Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Shinpoong Pharmaceutical Co?

The current dividend yield of Shinpoong Pharmaceutical Co is 0.76 %.

When does Shinpoong Pharmaceutical Co pay dividends?

Shinpoong Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of January, January, January, January.

How secure is the dividend of Shinpoong Pharmaceutical Co?

Shinpoong Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Shinpoong Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Shinpoong Pharmaceutical Co located?

Shinpoong Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shinpoong Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shinpoong Pharmaceutical Co from 4/23/2021 amounting to 100 KRW, you needed to have the stock in your portfolio before the ex-date on 12/29/2020.

When did Shinpoong Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 4/23/2021.

What was the dividend of Shinpoong Pharmaceutical Co in the year 2023?

In the year 2023, Shinpoong Pharmaceutical Co distributed 0 KRW as dividends.

In which currency does Shinpoong Pharmaceutical Co pay out the dividend?

The dividends of Shinpoong Pharmaceutical Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shinpoong Pharmaceutical Co

Our stock analysis for Shinpoong Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shinpoong Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.